Raymond James & Associates Buys 70,999 Shares of Kimberly-Clark Co. (NYSE:KMB)

→ A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad)

Raymond James & Associates boosted its stake in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) by 5.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,415,085 shares of the company's stock after purchasing an additional 70,999 shares during the period. Raymond James & Associates owned about 0.42% of Kimberly-Clark worth $183,041,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in KMB. OFI Invest Asset Management purchased a new stake in Kimberly-Clark during the third quarter valued at $25,000. Rise Advisors LLC grew its stake in shares of Kimberly-Clark by 926.3% during the 1st quarter. Rise Advisors LLC now owns 195 shares of the company's stock valued at $25,000 after purchasing an additional 176 shares during the period. Cranbrook Wealth Management LLC increased its position in shares of Kimberly-Clark by 90.9% during the 4th quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company's stock valued at $26,000 after purchasing an additional 100 shares during the last quarter. Accordant Advisory Group Inc bought a new position in shares of Kimberly-Clark in the 1st quarter worth approximately $27,000. Finally, Centerpoint Advisors LLC boosted its holdings in shares of Kimberly-Clark by 175.0% in the third quarter. Centerpoint Advisors LLC now owns 275 shares of the company's stock worth $33,000 after buying an additional 175 shares during the last quarter. Institutional investors own 76.29% of the company's stock.

Insider Buying and Selling


In other news, Director Mark T. Smucker bought 827 shares of Kimberly-Clark stock in a transaction dated Monday, January 29th. The shares were acquired at an average price of $120.98 per share, with a total value of $100,050.46. Following the completion of the purchase, the director now owns 827 shares in the company, valued at approximately $100,050.46. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, insider Paula Ramos sold 10,178 shares of the business's stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $137.17, for a total transaction of $1,396,116.26. Following the completion of the transaction, the insider now owns 795 shares in the company, valued at approximately $109,050.15. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Mark T. Smucker purchased 827 shares of the firm's stock in a transaction dated Monday, January 29th. The shares were bought at an average cost of $120.98 per share, with a total value of $100,050.46. Following the purchase, the director now directly owns 827 shares of the company's stock, valued at approximately $100,050.46. The disclosure for this purchase can be found here. 0.62% of the stock is owned by corporate insiders.

Kimberly-Clark Price Performance

Shares of NYSE:KMB traded down $1.19 during mid-day trading on Friday, reaching $135.24. The stock had a trading volume of 2,123,919 shares, compared to its average volume of 2,437,404. The business's 50 day moving average price is $125.86 and its 200 day moving average price is $122.92. Kimberly-Clark Co. has a 1 year low of $116.32 and a 1 year high of $147.09. The company has a market cap of $45.54 billion, a P/E ratio of 24.86, a price-to-earnings-growth ratio of 3.86 and a beta of 0.40. The company has a current ratio of 0.81, a quick ratio of 0.54 and a debt-to-equity ratio of 6.05.

Kimberly-Clark (NYSE:KMB - Get Free Report) last posted its quarterly earnings data on Tuesday, April 23rd. The company reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.61 by $0.40. The business had revenue of $5.15 billion during the quarter, compared to analyst estimates of $5.08 billion. Kimberly-Clark had a return on equity of 250.28% and a net margin of 9.05%. The company's revenue for the quarter was down .9% on a year-over-year basis. During the same period last year, the company earned $1.67 EPS. Research analysts expect that Kimberly-Clark Co. will post 7 EPS for the current fiscal year.

Analyst Ratings Changes

KMB has been the subject of a number of research reports. JPMorgan Chase & Co. upped their target price on shares of Kimberly-Clark from $115.00 to $123.00 and gave the company an "underweight" rating in a report on Wednesday. The Goldman Sachs Group raised their target price on Kimberly-Clark from $135.00 to $152.00 and gave the stock a "buy" rating in a report on Wednesday. UBS Group boosted their price target on Kimberly-Clark from $135.00 to $138.00 and gave the company a "neutral" rating in a report on Wednesday. Wells Fargo & Company lifted their price objective on Kimberly-Clark from $131.00 to $136.00 and gave the company an "equal weight" rating in a research report on Wednesday. Finally, Royal Bank of Canada increased their target price on shares of Kimberly-Clark from $123.00 to $126.00 and gave the stock a "sector perform" rating in a report on Wednesday. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $134.85.

View Our Latest Analysis on KMB

Kimberly-Clark Profile

(Free Report)

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.

Featured Stories

Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB - Free Report).

Institutional Ownership by Quarter for Kimberly-Clark (NYSE:KMB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Kimberly-Clark right now?

Before you consider Kimberly-Clark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.

While Kimberly-Clark currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Featured Articles and Offers

Search Headlines: